Skip to main navigation Skip to search Skip to main content

Synthesis of 2-acetamido-1,2-dideoxy-d-galacto-nojirimycin [DGJNAc] from d-glucuronolactone: the first sub-micromolar inhibitor of α-N-acetylgalactosaminidases

  • Daniel Best
  • , Phoom Chairatana
  • , Andreas F.G. Glawar
  • , Elizabeth Crabtree
  • , Terry D. Butters
  • , Francis X. Wilson
  • , Chu Yi Yu
  • , Wu Bao Wang
  • , Yue Mei Jia
  • , Isao Adachi
  • , Atsushi Kato
  • , George W.J. Fleet
  • Oxford University Clinical Academic Graduate School
  • University of Oxford Medical Sciences Division
  • Summit PLC
  • Institute of Chemistry Chinese Academy of Sciences
  • Toyama Medical and Pharmaceutical University

Research output: Contribution to journalArticlepeer-review

28 Citations (Scopus)

Abstract

2-Acetamido-1,2-dideoxy-d-galacto-nojirimycin [DGJNAc], prepared in 20% overall yield from d-glucuronolactone, is the first potent competitive sub-micromolar inhibitor of α-N-acetyl-galactosaminidases (Ki 0.081 μM from chicken liver, Ki 0.136 μM from Charonia lampas). DGJNAc is a good competitive-whereas the enantiomer l-DGJNAc is a very weak but non-competitive-inhibitor of β-hexosaminidases.

Original languageEnglish
Pages (from-to)2222-2224
Number of pages3
JournalTetrahedron Letters
Volume51
Issue number17
DOIs
Publication statusPublished - 28 Apr 2010
Externally publishedYes

Fingerprint

Dive into the research topics of 'Synthesis of 2-acetamido-1,2-dideoxy-d-galacto-nojirimycin [DGJNAc] from d-glucuronolactone: the first sub-micromolar inhibitor of α-N-acetylgalactosaminidases'. Together they form a unique fingerprint.

Cite this